209 related articles for article (PubMed ID: 7223659)
1. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
Olowoyeye JO; Thadani U; Parker JO
Am J Cardiol; 1981 May; 47(5):1123-7. PubMed ID: 7223659
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
Majid PA; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729
[TBL] [Abstract][Full Text] [Related]
3. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
Thadani U; Davidson C; Singleton W; Taylor SH
Am J Med; 1980 Feb; 68(2):243-50. PubMed ID: 6101934
[TBL] [Abstract][Full Text] [Related]
4. Propranolol in angina pectoris. Comparison of long-acting and standard-formulation propranolol.
Parker JO; Porter A; Parker JD
Circulation; 1982 Jun; 65(7):1351-5. PubMed ID: 6804113
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
Thadani U; Davidson C; Singleton W; Taylor SH
N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
Jones GR; Mir MA
Br Heart J; 1981 Nov; 46(5):503-7. PubMed ID: 6119104
[TBL] [Abstract][Full Text] [Related]
7. Experience with a sustained-release formulation of oxprenolol in the management of angina pectoris in hospital out-patient departments.
Forrest WA
Curr Med Res Opin; 1978; 5(9):669-74. PubMed ID: 104825
[TBL] [Abstract][Full Text] [Related]
8. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
Thadani U; Parker JO
Am J Cardiol; 1979 Jul; 44(1):118-25. PubMed ID: 377932
[TBL] [Abstract][Full Text] [Related]
9. Effect on exercise tolerance and pharmacokinetics of conventional and sustained release preparations of propranolol in patients with angina pectoris--a double-blind cross-over study.
Kambara H; Kinoshita M; Hirota Y; Kadota K; Sawamura M; Saito T; Kawai C
Jpn Circ J; 1984 Oct; 48(10):1066-73. PubMed ID: 6387210
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris.
Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
Eur J Clin Pharmacol; 1987; 32(2):127-33. PubMed ID: 3556193
[TBL] [Abstract][Full Text] [Related]
11. Comparison of slow-release pindolol, standard pindolol, and propranolol in angina pectoris.
Parker JO
Am J Cardiol; 1983 Apr; 51(7):1062-6. PubMed ID: 6404149
[TBL] [Abstract][Full Text] [Related]
12. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Ravid M; Lang R; Jutrin I
Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
[TBL] [Abstract][Full Text] [Related]
13. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
Uusitalo AJ; Keyriläinen O
Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group.
Narahara KA
Am J Cardiol; 1990 Mar; 65(9):577-82. PubMed ID: 2178381
[TBL] [Abstract][Full Text] [Related]
15. Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily.
Müller FB; Allsopp LF; Cooper GL; Bolli P; Frei P; Glaus L; Ritz R; Bühler FR
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):207S-212S. PubMed ID: 4005124
[TBL] [Abstract][Full Text] [Related]
16. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.
Jackson G; Harry JD; Robinson C; Kitson D; Jewitt DE
Br Heart J; 1978 Sep; 40(9):998-1004. PubMed ID: 101223
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
[TBL] [Abstract][Full Text] [Related]
18. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
[TBL] [Abstract][Full Text] [Related]
19. Comparison of adrenergic beta-receptor antagonists in angina pectoris.
Thadani U; Sharma B; Meeran MK; Majid PA; Whitaker W; Taylor SH
Br Med J; 1973 Jan; 1(5846):138-42. PubMed ID: 4145234
[TBL] [Abstract][Full Text] [Related]
20. A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertension.
Resnekov EB; Havard CW
Eur J Clin Pharmacol; 1978 Nov; 14(2):77-81. PubMed ID: 363434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
